Quantbot Technologies LP Adverum Biotechnologies, Inc. Transaction History

Quantbot Technologies LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 09, 2021	SELL	$2.08 - $3.6 $65,312 - $113,040	-31,400 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$3.36 - $10.56 $105,504 - $331,584	31,400 New	31,400 $109,000
Q4 2020 Feb 12, 2021	SELL	$9.84 - $14.26 $93,480 - $135,470	-9,500 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$10.3 - $21.64 $97,850 - $205,580	9,500 New	9,500 $97,000
Q3 2019 Nov 12, 2019	SELL	$5.24 - $15.89 $9,432 - $28,602	-1,800 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$5.1 - $11.89 $9,180 - $21,402	1,800 New	1,800 $21,000

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $471M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.